Quick Takeaways
- VANGUARD GROUP INC filed SCHEDULE 13G/A for CytoSorbents Corp Common Stock (CTSO).
- Disclosed ownership: 3.1%.
- Date of event: 31 Mar 2025.
VANGUARD GROUP INC - 31 Mar 2025 SCHEDULE 13G/A Report for CytoSorbents Corp Common Stock (CTSO)
- Filing Manager
- VANGUARD GROUP INC
- Reporting Manager
- The Vanguard Group
- Security
- CytoSorbents Corp Common Stock
- Symbol
- CTSO
- Shares outstanding
- 62,686,527 shares
- Disclosed Ownership
- 1,949,551 shares
- Ownership
- 3.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 30 Apr 2025, 10:59:27 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 31 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"VANGUARD GROUP INC disclosed 3.1% ownership in CytoSorbents Corp Common Stock (CTSO) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 31 Jan 2025.
- Current filing was accepted on 30 Apr 2025, 10:59.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Vanguard Group | 3.1% | 1,949,551 | 0 | 0 | Ashley Grim | Head of Global Fund Administration |